Live Breaking News & Updates on Janssen pharmaceuticals inc

Stay informed with the latest breaking news from Janssen pharmaceuticals inc on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Janssen pharmaceuticals inc and stay connected to the pulse of your community

Nevada Attorney General settles with Johnson and Johnson over Risperdal disclosure

Nevada Attorney General Catherine Cortez Masto announced Thursday that she and 36 other AGs reached a record $181 million settlement, the largest multi-state consumer protection settlement of its kind reached with a pharmaceutical company, with Janssen Pharmaceuticals, Inc., a subsidiary of Johnson and Johnson.

Nevada , United-states , Florida , Nevadans , Paule-stuhff , Catherine-cortez-masto , Risperdal-consta , Jo-ann-gibbs , Janssen-pharmaceuticals-inc , Bureau-of-consumer-protection , Drug-administration , Attorney-general-catherine-cortez-masto

Addex to Present at the Swiss Biotech Day 2024

Geneva, Switzerland, April 19, 2024 - Addex Therapeutics , a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug development, announced today that CEO, Tim Dyer, will...

Switzerland , United-states , Geneva , Genè , American , Swiss , Mike-sinclair , Tim-dyer , Janssen-pharmaceuticals-inc , Congress-center , Swiss-exchange , Nasdaq

Addex Therapeutics to Release Full-Year 2023 Financial Results and Host Conference Call on April 18, 2024

Addex Therapeutics to Release Full-Year 2023 Financial Results and Host Conference Call on April 18, 2024
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Geneva , Genè , Switzerland , United-states , American , Swiss , Tim-dyer , Mike-sinclair , Mikhail-kalinichev , Swiss-exchange , Janssen-pharmaceuticals-inc , Nasdaq

Janssen v. Teva: Not an April Fool's Day Joke for Life Sciences Companies | Goodwin

Janssen v. Teva: Not an April Fool's Day Joke for Life Sciences Companies | Goodwin
jdsupra.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jdsupra.com Daily Mail and Mail on Sunday newspapers.

Janssen-pharmaceuticals-inc , International-publication-no , Teva-pharmaceuticals-united-states-inc , Federal-circuit , Janssen-pharmaceuticals , Pharmaceuticals-united-states , International-publication ,

Rockland mulls committee to decide how to spend opioid settlement

ROCKLAND — The City Council will vote Monday evening April 8 on a proposal to create a committee that will recommend how Rockland should spend its proceeds from a national

Maine , United-states , Rockland , Rockland-public-library , American , Rockland-community-fruit-trees , Cardinal-health , Johnson , Amerisourcebergen , City-council , Rockland-rotary-club

Neurosterix Launches With $63M in Funding

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Geneva , Genè , Switzerland , Tim-dyer , Perceptive-xontogeny-venture-fund , Perceptive-life-sciences-fund , Janssen-pharmaceuticals-inc , Janssen-pharmaceuticals ,

Addex and Perceptive Launch Neurosterix with $63 Million to Accelerate Development of Allosteric Modulator Therapeutics for Neurological Disorders

Addex receives CHF5M and 20% share of Neurosterix  Perceptive Advisors leads $63M investment into Neurosterix  Addex contributes portfolio of preclinical neuroscience assets and...

United-states , Switzerland , New-york , Geneva , Genè , Swiss , American , Addex-neurosterix , Fred-callori , Jean-philippe-rocher , Mike-sinclair , Robert-lutjens

Neurosterix launches with $63M to Advance Allosteric Modulator Therapeutics for Neurological Disorders

Neurosterix launches with $63M to Advance Allosteric Modulator Therapeutics for Neurological Disorders
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Geneva , Genè , Switzerland , New-york , United-states , American , Swiss , Dennis-riedl , Tim-dyer , Fred-callori , Swiss-exchange , Perceptive-life-sciences-fund

Addex and Perceptive Launch Neurosterix with $63 Million to

Addex receives CHF5M and 20% share of Neurosterix  Perceptive Advisors leads $63M investment into Neurosterix  Addex contributes portfolio of...

New-york , United-states , Switzerland , Geneva , Genè , American , Swiss , Mikhail-kalinichev , Tim-dyer , Fred-callori , Robert-lutjens , Jean-philippe-rocher

Ankylosing Spondylitis Treatment Market Is Expected To Exhibit

Ankylosing Spondylitis Treatment Market Is Expected To Exhibit
openpr.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from openpr.com Daily Mail and Mail on Sunday newspapers.

Market-research , Janssen-pharmaceuticals-inc , Abbvie-inc , Amgen , Pfizer-inc , Sandoz-international-gmb , Allied-market-research , Spondylitis-market , Global-opportunity-analysis , Industry-forecast , Ankylosing-spondylitis